Drugs / CD3/CD28 stimulated T cells
last change Dec 2018 re-read 3 minutes ago

CD3/CD28 stimulated T cells

Developed for
chronic lymphocytic leukemia/small lymphocytic lymphoma
Investigated by
M.D. Anderson Cancer Center · University of Pennsylvania

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT01013441 Mar 2009 → Dec 2018 chronic lymphocytic leukemia/small lymphocytic lymphoma University of Pennsylvania Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CD3/CD28 stimulated T cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01013441 ↗